Orphazyme (Denmark) Today
| ORPHA Stock | DKK 1,100 49.80 4.74% |
Performance0 of 100
| Odds Of DistressLess than 48
|
Orphazyme is trading at 1099.80 as of the 18th of April 2024, a 4.74 percent up since the beginning of the trading day. The stock's open price was 1050.0. Orphazyme has 48 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Orphazyme AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of February 2024 and ending today, the 18th of April 2024. Click here to learn more.
Orphazyme AS, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. Orphazyme is traded on Copenhagen Stock Exchange in Denmark. The company has 35.31 M outstanding shares. More on Orphazyme AS
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Orphazyme Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Orphazyme's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Orphazyme or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Anders Hinsby |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Orphazyme AS (ORPHA) is traded on Copenhagen Exchange in Denmark and employs 2 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 30.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orphazyme's market, we take the total number of its shares issued and multiply it by Orphazyme's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Orphazyme AS operates under Biotechnology sector and is part of Health Care industry. The entity has 35.31 M outstanding shares.
Orphazyme AS has accumulated about 726.93 M in cash with (602.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.8.
Check Orphazyme Probability Of Bankruptcy
Ownership AllocationOrphazyme owns a total of 35.31 Million outstanding shares. Roughly 91.0 pct. of Orphazyme outstanding shares are held by general public with 1.36 % owned by insiders and only 8.13 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Orphazyme Ownership Details
Orphazyme Stock Price Odds Analysis
What are Orphazyme's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Orphazyme jumping above the current price in 90 days from now is about 80.87%. The Orphazyme AS probability density function shows the probability of Orphazyme stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Orphazyme AS has a beta of -0.3114. This indicates as returns on the benchmark increase, returns on holding Orphazyme are expected to decrease at a much lower rate. During a bear market, however, Orphazyme AS is likely to outperform the market. Additionally, orphazyme AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Orphazyme to move above the current price in 90 days from now is about 80.87 (This Orphazyme AS probability density function shows the probability of Orphazyme Stock to fall within a particular range of prices over 90 days) .
Orphazyme AS Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Orphazyme market risk premium is the additional return an investor will receive from holding Orphazyme long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Orphazyme. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Orphazyme's alpha and beta are two of the key measurements used to evaluate Orphazyme's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.56 | |||
| Standard Deviation | 4.98 | |||
| Variance | 24.81 | |||
| Risk Adjusted Performance | (0.01) |
Orphazyme Stock Against Markets
Picking the right benchmark for Orphazyme stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Orphazyme stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Orphazyme is critical whether you are bullish or bearish towards Orphazyme AS at a given time. Please also check how Orphazyme's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Orphazyme without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Orphazyme Corporate Directors
Orphazyme corporate directors refer to members of an Orphazyme board of directors. The board of directors generally takes responsibility for the Orphazyme's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Orphazyme's board members must vote for the resolution. The Orphazyme board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Remi Droller | Director | Profile | |
| Anders Hedegaard | Director | Profile | |
| Catherine Moukheibir | Director | Profile | |
| Sten Verland | Director | Profile |
How to buy Orphazyme Stock?
Before investing in Orphazyme, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Orphazyme. To buy Orphazyme stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Orphazyme. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Orphazyme stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Orphazyme AS stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Orphazyme AS stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Orphazyme AS, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Orphazyme AS?
The danger of trading Orphazyme AS is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Orphazyme is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Orphazyme. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Orphazyme AS is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orphazyme AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Orphazyme AS information on this page should be used as a complementary analysis to other Orphazyme's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Orphazyme Stock analysis
When running Orphazyme's price analysis, check to measure Orphazyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orphazyme is operating at the current time. Most of Orphazyme's value examination focuses on studying past and present price action to predict the probability of Orphazyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orphazyme's price. Additionally, you may evaluate how the addition of Orphazyme to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |